People who recall being absolved of their sins, are more likely to donate money to the church, according to research published today in the journal Religion, Brain and Behavior.
Researchers from Royal Holloway and the University of Oxford assigned participants two memory tasks. In the first, they were asked to privately recall a sin that they had committed in the past, while in the second, they recalled attending confession for this sin or imagined doing so, if they had not confessed in reality.
Each participant was also given an opportunity to donate to a local Catholic church by placing some money in an envelope. For some participants, this donation was collected before they recalled being absolved of the sin, whereas for others the donation was collected afterward.
The results showed that recalling (or imagining) absolution strongly increased church donations, with the effect more pronounced in participants who believed in divine judgment and engaged in religious activities such as reading the bible or praying.
Dr Ryan McKay from the Department of Psychology at Royal Holloway said: "Recent evidence has suggested that people are more likely to behave prosocially, such as helping, sharing, donating, co-operating and volunteering, when they feel guilty. This raises the question of whether religious rituals of absolution, in which people are absolved of their sins and released from guilt, would actually make people less prosocial.
"However, the results of our study suggest the opposite - that 'releasing' people from their sin has a positive prosocial effect. This indicates that the Catholic ritual of confession is an effective means of promoting commitment to the church"
Many other religions feature the concept of absolution in varying forms, such as Prāyaścitta in the Hindu tradition and Istighfar in Islam. The researchers are now keen to see if similar results would be seen beyond Catholicism. The research is part of a wider project on 'Ritual, Community and Conflict' supported by the Economic and Social Research Council (ESRC).
Royal Holloway, University of London: http://www.rhul.ac.uk
This press release was posted to serve as a topic for discussion. Please comment below. We try our best to only post press releases that are associated with peer reviewed scientific literature. Critical discussions of the research are appreciated. If you need help finding a link to the original article, please contact us on twitter or via e-mail.
Doctors have used perfect replicas of childrens' hearts to uncover and repair hidden defects
An experiment testing people’s altruism in the face of electric shocks is clear on one thing: we are drawn to these little blasts
Researchers gear up tests in West Africa to see whether blood from Ebola survivors can help people who are sick with the disease. This is part of a broader effort to test therapies in West Africa.
The virus's foray into Europe coincides with peak production of Christmas turkeys, the poultry species most vulnerable to bird flu
A novel kind of nanoparticle could lead to more effective cancer treatments.Patients and doctors often don’t know if surgery to remove cancerous tissue was successful until scans are performed months later. A new kind of nanoparticle could show patients if they’re in the clear much earlier.
One challenge in evaluating the effectiveness of different medical procedures, is that patients behave differently after different procedures. Is this true for patients getting heart surgery?
It is only in the aftermath of treatment that survivors discern that their adrenalin alone wont fuel the rest of their recovery. For many, surviving cancer is followed by even more hardship
Just down the road from Facebook and Google, Dr. Phil Wagner runs a laboratory dedicated to optimizing the performance of some of the world's top athletes. At Sparta Performance Science in Menlo Park, California, Wagner and his team bring the spirit of Silicon Valley to bear on the athletic world, helping athletes find the tiny advantages that add to championships. Join us for a trip inside the lab to see where sports meets science.
Pieter Cohen, an internist in Massachusetts, got interested in dietary supplements several years ago, when some of his …
The risk of overdiagnosis and false positives means the UK may be barking up the wrong tree in trialling a wider target age range for breast screening